GlassScriptPhysician profile
Gregory L Condie
NPI 1255691986
$8,073.88
in general payments reported to CMS, 2019-2025
50 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,270 · 2020: $589 · 2021: $436 · 2022: $523 · 2023: $1,882 · 2024: $1,977 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,210 · Travel and Lodging: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,209.52 |
| Travel and Lodging | $1,046.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,066.30 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Medtronic, INC. | $883.81 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Relievant Medsystems, INC. | $854.79 | 2021-2023 | Intracept |
| Abbvie INC. | $580.52 | 2021-2025 | Botox |
| Collegium Pharmaceutical, INC. | $576.91 | 2022-2025 | Belbuca, Xtampza |
| Pfizer INC. | $464.59 | 2019-2025 | |
| Globus Medical, INC. | $437.24 | 2025 | Senza |
| Abbott Laboratories | $390.86 | 2019-2025 | Eterna |
| Biodelivery Sciences International, INC. | $249.13 | 2019-2021 | |
| Indivior INC. | $206.53 | 2019-2025 | Sublocade |
| Amgen INC. | $205.76 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $172.67 | 2019-2025 | Relistor |
| Nevro Corp. | $146.17 | 2019-2022 | |
| Zyla Life Sciences, INC. | $135.60 | 2019-2020 | |
| Zimvie INC. | $120.60 | 2024 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Condie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.